Charles Schwab Investment Management »

Axsome Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 296k 79.59
2023-09-30 $20M 290k 69.89
2023-06-30 $19M 268k 71.86
2023-03-31 $15M 249k 61.68
2022-12-31 $19M 250k 77.13
2022-09-30 $10M 226k 44.62
2022-06-30 $8.2M 214k 38.30
2022-03-31 $8.8M 213k 41.39
2021-12-31 $7.8M 207k 37.78
2021-09-30 $6.7M 204k 32.96
2021-06-30 $13M 186k 67.46
2021-03-31 $10M 183k 56.62
2020-12-31 $14M 177k 81.47
2020-09-30 $13M 175k 71.25
2020-06-30 $15M 181k 82.28
2020-03-31 $9.9M 168k 58.83
2019-12-31 $17M 160k 103.36
2019-09-30 $3.1M 153k 20.24
2019-06-30 $1.5M 57k 25.75
2017-03-31 $70k 18k 3.95
2016-12-31 $120k 18k 6.78
2016-09-30 $140k 18k 7.91
2016-06-30 $134k 18k 7.57